Compile Data Set for Download or QSAR
Report error Found 44 Enz. Inhib. hit(s) with all data for entry = 1552
TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330331BDBM330331(US9725426, 2-hydrazinylacetic acid)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330299BDBM330299(US9725426, 3)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330300BDBM330300(US9725426, 4)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330319BDBM330319(US9725426, 23)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330318BDBM330318(US9725426, 22)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330321BDBM330321(US9725426, 25)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330320BDBM330320(US9725426, 24)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330322BDBM330322(US9725426, 26)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330324BDBM330324(US9725426, 28)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330311BDBM330311(US9725426, 15)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330317BDBM330317(US9725426, 21)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330316BDBM330316(US9725426, 20)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330339BDBM330339(US9725426, (E)-5-(2-(furan-2-ylmethylene)hydraziny...)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330307BDBM330307(US9725426, 11)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330309BDBM330309(US9725426, 13)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330308BDBM330308(US9725426, 12)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330327BDBM330327(US9725426, 32)
Affinity DataIC50: 5.50E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330297BDBM330297(US9725426, 1)
Affinity DataIC50: 5.50E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330333BDBM330333(US9725426, 4-((2-(1H-tetrazol-5-yl)hydrazinyl)meth...)
Affinity DataIC50: 5.50E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330332BDBM330332(US9725426, 2-(2-(propan-2-ylidene)hydrazinyl)aceti...)
Affinity DataIC50: 5.50E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330323BDBM330323(US9725426, 27)
Affinity DataIC50: 5.50E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330310BDBM330310(US9725426, 14)
Affinity DataIC50: 5.50E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330313BDBM330313(US9725426, 17)
Affinity DataIC50: 5.50E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330312BDBM330312(US9725426, 16)
Affinity DataIC50: 5.50E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330314BDBM330314(US9725426, 18)
Affinity DataIC50: 5.50E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330303BDBM330303(US9725426, 7)
Affinity DataIC50: 5.50E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330334BDBM330334(US9725426, (E)-4-((2-(1H-tetrazol-5-yl)hydrazono)m...)
Affinity DataIC50: 5.50E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330302BDBM330302(US9725426, 6)
Affinity DataIC50: 5.50E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330337BDBM330337(US9725426, (E)-4-((2-(1H-tetrazol-5-yl)hydrazono)m...)
Affinity DataIC50: 5.50E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330340BDBM330340(US9725426, 5-hydrazinyl-1H-tetrazole)
Affinity DataIC50: 5.50E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330326BDBM330326(US9725426, 31)
Affinity DataIC50: 1.00E+5nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330329BDBM330329(US9725426, 34)
Affinity DataIC50: 1.00E+5nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330328BDBM330328(US9725426, 33)
Affinity DataIC50: 1.00E+5nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330330BDBM330330(US9725426, 35)
Affinity DataIC50: 1.00E+5nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330298BDBM330298(US9725426, 2)
Affinity DataIC50: 1.00E+5nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330301BDBM330301(US9725426, 5)
Affinity DataIC50: 1.00E+5nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330325BDBM330325(US9725426, 29)
Affinity DataIC50: 1.00E+5nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330315BDBM330315(US9725426, 19)
Affinity DataIC50: 1.00E+5nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330335BDBM330335(US9725426, (E)-1-((2-(1H-tetrazol-5-yl)hydrazono)m...)
Affinity DataIC50: 1.00E+5nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330305BDBM330305(US9725426, 9)
Affinity DataIC50: 1.00E+5nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330336BDBM330336(US9725426, (E)-5-(2-(benzo[d][1,3]dioxol-5-ylmethy...)
Affinity DataIC50: 1.00E+5nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330304BDBM330304(US9725426, 8)
Affinity DataIC50: 1.00E+5nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330338BDBM330338(US9725426, (E)-5-(2-(4-nitrobenzylidene)hydrazinyl...)
Affinity DataIC50: 1.00E+5nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 330306BDBM330306(US9725426, 10)
Affinity DataIC50: 1.00E+5nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent